Rhabdomyolysis after ingestion of "foxy," a hallucinogenic tryptamine derivative.
Gheath Alatrash, Navneet S Majhail, James C Pile
Mayo Clinic proceedings April 1, 2006 DOI: 10.4065/81.4.550 via PubMed
Summary
AI-generated from the abstractA hallucinogenic drug called foxy methoxy (5-methoxy-N,N-diisopropyltryptamine) has been used with increasing frequency since the late 1990s. It produces euphoria, disinhibition, and auditory and visual hallucinations, but has also been linked to restlessness, agitation, gastrointestinal distress, and muscle tension. Because commercial toxicology tests cannot detect hallucinogenic tryptamines, additional adverse effects are probable. A case is reported of a healthy 23-year-old man who ingested foxy and developed rhabdomyolysis and transient acute renal failure.
Study at a glance
| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | Healthy 23-year-old man |
| Citations | 108 |
| Key finding | Ingestion of foxy methoxy can cause rhabdomyolysis and transient acute renal failure. |
Abstract
"Foxy methoxy" (chemical name, 5-methoxy-N,N-diisopropyltryptamine) is a hallucinogenic tryptamine that has been abused with increasing frequency since its appearance in the late 1990s. Like other drugs in this class, foxy frequently produces feelings of euphoria, disinhibition, and auditory as well as visual hallucinations. The drug has been linked to adverse effects, including restlessness, agitation, gastrointestinal distress, and muscle tension. In light of the relatively recent advent of foxy as a drug of abuse and given the inability of commercial toxicologic screening tests to detect the presence of hallucinogenic tryptamines, additional adverse effects seem probable. We report ingestion of foxy by a healthy 23-year-old man that resulted in rhabdomyolysis and transient acute renal failure.